Emphysema is mainly a clinical chronic obstructive pulmonary disease, and in the treatment of emphysema, nebulizer therapy is available and generally effective. The nebulized inhalation drugs for the treatment of emphysema are mainly glucocorticoids, including sulforaphane, Cymbalta, and tiotropium bromide Tiotropium bromide is an anticholinergic bronchodilator, and these three drugs can be used alone or in combination to provide anti-inflammatory, antispasmodic, asthma, and protection of lung function. Terbutaline and salbutamol aerosols can also be used, which are mainly antispasmodic, wheezing, diastolic bronchial smooth muscle, as well as relieving cough, cough and wheezing. Therefore, emphysema patients doing nebulization usually use glucocorticoids in combination, as well as β2 agonists, both of which can be used alone or in combination according to the condition, in order to control the clinical manifestations of COPD as soon as possible.